Healthcare provider profile · identity verified

Glenn Zeidman, DO

Family Practice · MCCOMB, MS · NPI 1023067360

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1256	43
Amlodipine Besylate	Amlodipine Besylate	921	36
Furosemide	Furosemide	805	36
Potassium Chloride	Potassium Chloride	669	26
Buspirone Hcl	Buspirone Hcl	635	22
Sertraline Hcl	Sertraline Hcl	571	17
Gabapentin	Gabapentin	564	23
Levothyroxine Sodium	Levothyroxine Sodium	557	24
Carvedilol	Carvedilol	530	18
Clopidogrel	Clopidogrel Bisulfate	516	15
Pantoprazole Sodium	Pantoprazole Sodium	479	25
Metformin Hcl	Metformin Hcl	434	14
Quetiapine Fumarate	Quetiapine Fumarate	409	16
Eliquis	Apixaban	347	20
Hydrochlorothiazide	Hydrochlorothiazide	339	13
Levetiracetam	Levetiracetam	314	11
Donepezil Hcl	Donepezil Hcl	309	13
Metoprolol Tartrate	Metoprolol Tartrate	303	11
Tamsulosin Hcl	Tamsulosin Hcl	294	14
Montelukast Sodium	Montelukast Sodium	291	suppressed
Losartan Potassium	Losartan Potassium	273	15
Trazodone Hcl	Trazodone Hcl	272	15
Famotidine	Famotidine	270	suppressed
Omeprazole	Omeprazole	236	18
Xarelto	Rivaroxaban	231	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	230	11
Lisinopril	Lisinopril	224	suppressed
Aripiprazole	Aripiprazole	220	suppressed
Duloxetine Hcl	Duloxetine Hcl	204	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	199	suppressed
Mirtazapine	Mirtazapine	177	suppressed
Baclofen	Baclofen	176	suppressed
Citalopram Hbr	Citalopram Hydrobromide	160	suppressed
Pravastatin Sodium	Pravastatin Sodium	154	suppressed
Midodrine Hcl	Midodrine Hcl	152	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	152	suppressed
Bupropion Xl	Bupropion Hcl	146	suppressed
Meloxicam	Meloxicam	146	suppressed
Simvastatin	Simvastatin	137	suppressed
Torsemide	Torsemide	135	suppressed
Amiodarone Hcl	Amiodarone Hcl	133	suppressed
Benztropine Mesylate	Benztropine Mesylate	133	suppressed
Memantine Hcl	Memantine Hcl	132	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	131	suppressed
Metoprolol Succinate	Metoprolol Succinate	131	suppressed
Haloperidol	Haloperidol	128	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	128	suppressed
Metolazone	Metolazone	127	suppressed
Divalproex Sodium	Divalproex Sodium	121	suppressed
Finasteride	Finasteride	118	suppressed
Meclizine Hcl	Meclizine Hcl	114	suppressed
Spironolactone	Spironolactone	111	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	107	suppressed
Lamotrigine	Lamotrigine	101	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	97	suppressed
Allopurinol	Allopurinol	95	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	94	suppressed
Verapamil Er	Verapamil Hcl	92	suppressed
Risperidone	Risperidone	89	suppressed
Topiramate	Topiramate	89	suppressed
Celecoxib	Celecoxib	87	suppressed
Fenofibrate	Fenofibrate	81	suppressed
Propranolol Hcl	Propranolol Hcl	76	suppressed
Hydralazine Hcl	Hydralazine Hcl	74	suppressed
Ramipril	Ramipril	73	suppressed
Valsartan	Valsartan	73	suppressed
Myrbetriq	Mirabegron	69	suppressed
Paroxetine Hcl	Paroxetine Hcl	68	suppressed
Chlorthalidone	Chlorthalidone	66	suppressed
Jardiance	Empagliflozin	66	suppressed
Metformin Hcl Er	Metformin Hcl	62	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	61	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	60	suppressed
Lovastatin	Lovastatin	56	suppressed
Tradjenta	Linagliptin	53	suppressed
Namzaric	Memantine Hcl/Donepezil Hcl	52	suppressed
Trintellix	Vortioxetine Hydrobromide	52	suppressed
Calcium Acetate	Calcium Acetate	51	suppressed
Nifedipine Er	Nifedipine	51	suppressed
Labetalol Hcl	Labetalol Hcl	50	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	50	suppressed
Januvia	Sitagliptin Phosphate	49	suppressed
Roflumilast	Roflumilast	49	suppressed
Diltiazem Hcl	Diltiazem Hcl	48	suppressed
Gemfibrozil	Gemfibrozil	48	suppressed
Insulin Lispro	Insulin Lispro	47	15
Ondansetron Hcl	Ondansetron Hcl	45	32
Ranolazine Er	Ranolazine	44	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	42	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	41	suppressed
Memantine Hcl Er	Memantine Hcl	40	suppressed
Glipizide	Glipizide	39	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	39	suppressed
Novolog	Insulin Aspart	37	suppressed
Clonidine Hcl	Clonidine Hcl	35	suppressed
Clozapine	Clozapine	35	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	35	suppressed
Flecainide Acetate	Flecainide Acetate	34	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	34	20
Fluticasone Propionate	Fluticasone Propionate	32	23
Ciprofloxacin Hcl	Ciprofloxacin Hcl	31	25
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	31	suppressed
Primidone	Primidone	31	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	31	suppressed
Carbamazepine Er	Carbamazepine	30	suppressed
Lithium Carbonate	Lithium Carbonate	30	suppressed
Sotalol Af	Sotalol Hcl	30	suppressed
Glipizide Er	Glipizide	28	suppressed
Galantamine Er	Galantamine Hbr	26	suppressed
Terazosin Hcl	Terazosin Hcl	26	suppressed
Trulicity	Dulaglutide	26	suppressed
Bupropion Hcl Sr	Bupropion Hcl	25	suppressed
Chlorpromazine Hcl	Chlorpromazine Hcl	25	suppressed
Divalproex Sodium Er	Divalproex Sodium	25	suppressed
Novolin R	Insulin Regular, Human	25	suppressed
Olanzapine Odt	Olanzapine	25	suppressed
Glimepiride	Glimepiride	24	suppressed
Mupirocin	Mupirocin	24	16
Triamcinolone Acetonide	Triamcinolone Acetonide	24	11
Amitriptyline Hcl	Amitriptyline Hcl	23	suppressed
Entresto	Sacubitril/Valsartan	23	suppressed
Lubiprostone	Lubiprostone	22	suppressed
Prednisone	Prednisone	22	20
Doxycycline Hyclate	Doxycycline Hyclate	21	19
Fluconazole	Fluconazole	21	15
Lidocaine Hcl	Lidocaine Hcl	21	18
Nuedexta	Dextromethorphan Hbr/Quinidine	21	suppressed
Warfarin Sodium	Warfarin Sodium	21	suppressed
Ibuprofen	Ibuprofen	20	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	19	16
Arexvy	Rsvpref3 Antigen/As01e/Pf	19	19
Levofloxacin	Levofloxacin	19	15
Semglee (Yfgn)	Insulin Glargine-Yfgn	19	suppressed
Amlodipine-Valsartan-Hctz	Amlodipine/Valsartan/Hcthiazid	18	suppressed
Perphenazine	Perphenazine	18	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	18	suppressed
Nystop	Nystatin	17	11
Scopolamine	Scopolamine	17	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Ceftriaxone	Ceftriaxone Sodium	16	12
Clindamycin Hcl	Clindamycin Hcl	16	12
Doxepin Hcl	Doxepin Hcl	16	suppressed
Levemir	Insulin Detemir	16	suppressed
Santyl	Collagenase Clostridium Hist.	16	suppressed
Tresiba Flextouch U-100	Insulin Degludec	16	suppressed
Phenytoin	Phenytoin	15	suppressed
Risperdal Consta	Risperidone Microspheres	15	suppressed
Clonidine	Clonidine	14	suppressed
Linzess	Linaclotide	14	suppressed
Methocarbamol	Methocarbamol	14	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	13	suppressed
Calcitriol	Calcitriol	13	suppressed
Fesoterodine Fumarate Er	Fesoterodine Fumarate	13	suppressed
Fluphenazine Hcl	Fluphenazine Hcl	13	suppressed
Gentamicin Sulfate	Gentamicin Sulfate	13	suppressed
Haloperidol Decanoate	Haloperidol Decanoate	13	suppressed
Insulin Aspart	Insulin Aspart	13	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	13	suppressed
Nystatin	Nystatin	13	suppressed
Paricalcitol	Paricalcitol	13	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	13	suppressed
Azithromycin	Azithromycin	12	12
Naltrexone Hcl	Naltrexone Hcl	12	suppressed
Carbamazepine	Carbamazepine	11	suppressed
Digoxin	Digoxin	11	suppressed
Insulin Aspart Flexpen	Insulin Aspart	11	suppressed
Naproxen	Naproxen	11	suppressed
Pilocarpine Hcl	Pilocarpine Hcl	11	suppressed
Triumeq	Abacavir/Dolutegravir/Lamivudi	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error